Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Information Officer

Gen. Counsel & Corp. Secy.

Head of Global Business Svcs

Corporate Controller

Head of Manufacturing

Chief Executive Officer

Chief Commercial Officer

Chief Human Resources Officer

Head of Ext. Affairs and ESG

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive; Nuvaring, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's heal...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-31	Premium	acquired	Premium	Premium	Premium	Chief Information Officer
2024-03-31	Premium	acquired	Premium	Premium	Premium	Gen. Counsel & Corp. Secy.
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Head of Global Business Svcs
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Corporate Controller
2024-03-31	Premium	acquired	Premium	Premium	Premium	Corporate Controller
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Gen. Counsel & Corp. Secy.
2024-03-31	Premium	acquired	Premium	Premium	Premium	Head of Manufacturing
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-03-31	Premium	acquired	Premium	Premium	Premium	Head of Global Business Svcs
2024-03-31	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-03-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-03-31	Premium	acquired	Premium	Premium	Premium	Chief Human Resources Officer
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Human Resources Officer
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Head of Manufacturing
2024-03-31	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Information Officer
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	Head of Manufacturing
2024-02-28	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	Head of Global Business Svcs
2024-02-28	Premium	acquired	Premium	Premium	Premium	Head of Manufacturing
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	Chief Information Officer
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	Chief Information Officer

OGN - Organon & Co. Stock Price, Fair Value and News

Latest Insider Trading transactions for OGN